To this point, simply over 540,000 monkeypox vaccine doses have been administered, in keeping with CDC information from 37 states and two cities — a fraction of the greater than three million doses wanted to totally vaccinate the individuals the federal government says are at highest danger of contracting the illness.
Criticism of how federal businesses dealt with the vaccine rollout centered on just a few key factors of the monkeypox response, together with early hold-ups in growing the nationwide provide of Jynneos, the FDA-approved monkeypox vaccine made by the Danish drugmaker Bavarian Nordic, due partially to the truth that the FDA wanted to approve a producing facility the place the vaccines are being made.
“We had virtually 800,000 vials [of Jynneos] sitting on the producer’s facility in Denmark, however the cargo of those critically wanted vaccines to the U.S. was held up, pending a FDA inspection of the ability regardless that European regulators had authorised it,” mentioned Sen. John Hickenlooper (D-Colo.)
FDA Commissioner Robert Califf defended the choice to formally approve the plant in July earlier than permitting the vaccines to be shipped to the U.S. “I in all probability don’t must remind you that we had multiple incident in Covid instances of a producing facility not being as much as par, which created loads of issue,” he mentioned. “We actually felt we needed to get this proper even when it took a bit extra time.”
Lawmakers additionally took problem with a call made by the Administration for Strategic Preparedness and Response to make use of a special system for well being departments to order the monkeypox vaccines than was used for Covid-19, which, they mentioned, created confusion and delay.
“This was occurring at a time when these challenges are falling on public well being departments and workers which might be exhausted and burned out after the final two-and-a -half years of responding to Covid-19,” mentioned Sen. Tina Smith (D-Minn.). “Studying a brand new system within the midst of all of that is actually a problem.”
ASPR Secretary Daybreak O’Connell mentioned the choice was made to make use of an present system that could possibly be used to order each remedies and vaccines, whereas the extra acquainted Covid-19 ordering system might solely be used to order vaccines.
HELP Chair Patty Murray (D-Wash.) acknowledged that the slowing of U.S. circumstances was an encouraging improvement, however warned the witnesses on the listening to — O’Connell, Califf, CDC Director Rochelle Walensky and Biden administration chief medical adviser Anthony Fauci — to stay vigilant.
“These promising enhancements don’t excuse the problems I’ve been listening to about from communities, from state well being officers, and advocates from the very begin of this outbreak,” Murray mentioned.
“We have to hold focusing and enhancing on outreach and on getting data and sources — like vaccines — to those that are most in want and most in danger, and that should embody communities of coloration who we all know should not have equitable entry to vaccines,” she mentioned.